IA
TARS icon

IFP Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

IFP Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Buy
18
+17
+1,700% +$1.09K ﹤0.01% 4459
2026
Q1 		$70 Hold
1
– – ﹤0.01% 4789
2025
Q4 		$82 Hold
1
– – ﹤0.01% 4633
2025
Q3 		$59 Sell
1
-47
-98% -$2.31K ﹤0.01% 4637
2025
Q2 		$1.95K Buy
48
+47
+4,700% +$2.12K ﹤0.01% 3912
2025
Q1 		$51 Hold
1
– – ﹤0.01% 4019
2024
Q4 		$55 Buy
+1
New +$45 ﹤0.01% 4232
2023
Q1 		– Sell
-30
Closed -$1K – 4328
2022
Q4 		$1K Buy
+30
New +$496 ﹤0.01% 4482

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IFP Advisors's TARS Position: Q2 2026 in Review

IFP Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 1,700% in Q2 2026, buying an estimated $1.09K and bringing the position to 18 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4459.

IFP Advisors first reported a position in TARS in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.95K in Q2 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • IFP Advisors held 18 shares of Tarsus Pharmaceuticals worth $1.13K as of Q2 2026.
  • IFP Advisors bought 17 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.09K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4459 holding.
  • IFP Advisors first reported a position in Tarsus Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • IFP Advisors's Tarsus Pharmaceuticals position peaked at $1.95K in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.